CN Stock MarketDetailed Quotes

300294 China Resources Boya Bio-pharmaceutical Group

Watchlist
  • 31.39
  • +0.17+0.54%
Noon Break Dec 2 11:30 CST
15.83BMarket Cap85.07P/E (TTM)

China Resources Boya Bio-pharmaceutical Group Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
48.09%1.99B
67.53%3.25B
8.73%1.86B
28.07%1.96B
22.16%1.34B
92.75%1.94B
91.83%1.71B
-3.29%1.53B
1.48%1.1B
39.13%1.01B
Transactional financial assets
-13.71%3.25B
-26.44%2.24B
15.00%3.71B
5.28%3.36B
7.89%3.77B
-11.66%3.05B
-5.16%3.22B
18.29%3.19B
271.41%3.49B
263.73%3.45B
Notes receivable and accounts receivable
17.60%303.49M
-29.57%322.24M
-49.14%240.86M
-54.56%209.84M
-51.19%258.06M
-20.01%457.52M
-10.76%473.59M
1.63%461.8M
4.13%528.75M
12.63%571.98M
-Notes receivable
--10.38M
--2.6M
----
----
----
----
----
-99.02%91.9K
----
----
-Accounts receivable
13.58%293.11M
-30.14%319.64M
-49.14%240.86M
-54.55%209.84M
-51.19%258.06M
-20.01%457.52M
-10.76%473.59M
3.74%461.71M
12.36%528.75M
32.76%571.98M
Other receivables (including interest and dividends)
-0.36%352.99M
278.34%191.11M
81.96%154.41M
162.77%264.4M
324.51%354.26M
-53.13%50.51M
-6.79%84.86M
48.20%100.62M
36.19%83.45M
74.29%107.77M
-Other receivable
----
278.34%191.11M
----
----
----
-53.13%50.51M
----
48.20%100.62M
----
74.29%107.77M
Advance payment
256.39%12.23M
-67.93%2.98M
-58.98%2.62M
-51.67%4.67M
-36.20%3.43M
130.49%9.29M
-28.52%6.39M
-25.75%9.66M
-56.44%5.38M
-63.08%4.03M
Inventories
8.26%627.58M
-0.80%577.32M
-8.30%566.51M
-16.50%556.94M
-11.76%579.7M
-11.86%581.97M
-7.83%617.82M
-1.46%666.96M
7.09%656.93M
0.36%660.29M
Receivable financing
-29.56%51.79M
-41.02%58.46M
-35.05%77.35M
-37.20%66.08M
-40.90%73.52M
3.36%99.12M
6.40%119.1M
-21.28%105.22M
2.56%124.41M
11.30%95.91M
Other current assets
109.07%1.33M
-74.24%320.58K
39.18%2.61M
-50.82%1.77M
-67.18%638.47K
348.01%1.24M
-87.80%1.88M
-78.09%3.59M
-87.48%1.95M
-98.18%277.81K
Total current assets
3.28%6.59B
7.40%6.65B
5.99%6.61B
5.83%6.43B
6.48%6.38B
4.94%6.19B
9.07%6.24B
7.57%6.07B
78.59%5.99B
95.78%5.9B
Non Current assets
Other non-current financial assets
-15.99%93.96M
-24.85%91M
-22.76%92.37M
-14.26%100.39M
-10.68%111.84M
-8.68%121.09M
-12.50%119.59M
-19.23%117.09M
--125.21M
--132.59M
Investment real estate
-7.63%611.25K
-7.52%623.83K
-12.73%636.42K
-7.30%649.01K
--661.76K
--674.52K
--729.27K
--700.08K
----
----
Fixed assets
----
-1.66%607.7M
----
----
----
-9.60%617.95M
----
-10.67%639.88M
----
-5.18%683.59M
Constru in process
----
-38.87%55.27M
----
----
----
61.02%90.41M
----
69.72%69.34M
----
-14.17%56.15M
Intangible assets
-16.13%263.14M
-16.21%267.21M
-13.80%265.81M
-13.73%269.31M
17.66%313.77M
95.42%318.89M
85.42%308.35M
84.21%312.17M
36.56%266.67M
-15.15%163.19M
Development expenditure
18.85%64.77M
29.91%61.19M
34.50%55.93M
40.49%53.22M
14.25%54.49M
-59.09%47.1M
-61.34%41.58M
-63.32%37.88M
-66.24%47.7M
-13.89%115.14M
Goodwill
-85.41%72.61M
-89.06%72.61M
-89.06%72.61M
-89.06%72.61M
-25.02%497.77M
0.00%663.84M
0.00%663.84M
0.00%663.84M
0.00%663.84M
0.00%663.84M
Long deferred expense
-16.29%42.3M
-23.87%31.32M
-23.80%33.01M
-21.95%34.93M
7.47%50.53M
-18.33%41.14M
-20.25%43.32M
-23.28%44.76M
-20.53%47.02M
-12.17%50.37M
Deferred tax assets
5.64%44.96M
9.51%50.09M
30.39%50.01M
5.22%47.34M
13.01%42.56M
42.31%45.74M
36.99%38.35M
63.98%44.99M
59.48%37.66M
68.76%32.14M
Usufruct assets
79.96%5.17M
-50.64%5.72M
-83.78%2.04M
-81.98%2.45M
-80.45%2.87M
-13.61%11.58M
-5.85%12.57M
-4.01%13.59M
7.45%14.68M
-7.20%13.41M
Other non current assets
849.18%192.26M
556.96%133.81M
611.19%146.95M
840.58%146.18M
-61.42%20.26M
-52.63%20.37M
-40.47%20.66M
-58.22%15.54M
23.38%52.5M
-22.91%43M
Total non current assets
-12.98%1.57B
-30.44%1.38B
-29.49%1.38B
-28.50%1.4B
-9.28%1.8B
1.30%1.98B
-0.09%1.96B
-0.81%1.96B
-3.89%1.99B
-13.91%1.95B
Total assets
-0.31%8.16B
-1.77%8.02B
-2.48%7.99B
-2.54%7.83B
2.55%8.18B
4.03%8.17B
6.73%8.2B
5.40%8.03B
47.13%7.98B
48.65%7.85B
Liabilities
Current liabilities
Notes payable and accounts payable
56.02%219.87M
-39.66%138.49M
-63.22%115.83M
-58.36%126.35M
-52.77%140.92M
-32.41%229.51M
3.68%314.94M
9.34%303.46M
18.52%298.36M
28.87%339.58M
-Notes payable
282.27%145.39M
63.77%67.73M
19.36%48.19M
50.37%49.74M
24.05%38.03M
21.78%41.36M
-9.92%40.38M
-34.46%33.08M
-61.86%30.66M
-60.80%33.96M
-Accounts payable
-27.62%74.47M
-62.39%70.76M
-75.36%67.64M
-71.67%76.61M
-61.57%102.89M
-38.44%188.15M
6.03%274.57M
19.08%270.38M
56.23%267.7M
72.78%305.62M
Contract liabilities
-31.24%4.03M
-29.13%5.79M
-26.91%8.15M
-40.68%12.21M
-67.58%5.86M
-12.53%8.18M
32.73%11.15M
58.59%20.58M
87.62%18.07M
-32.37%9.35M
Advance receipts
----
----
----
--110.56K
----
--2.14K
--4.29K
----
----
----
Salaries payable
0.16%89.75M
-24.66%75.4M
-24.96%63.67M
-17.82%82.67M
61.40%89.61M
129.34%100.08M
153.17%84.85M
35.51%100.6M
24.86%55.52M
8.59%43.64M
Taxs payable
-52.51%22.19M
12.82%41.02M
-23.26%41.43M
-52.49%24.47M
-17.65%46.73M
-42.02%36.36M
30.80%53.98M
-18.12%51.5M
-5.74%56.75M
65.87%62.71M
Other payable (including interest and dividends)
-22.65%209.72M
-8.80%223.61M
-8.33%238.76M
3.36%208.65M
29.80%271.15M
28.81%245.19M
36.81%260.45M
2.51%201.86M
23.94%208.9M
16.49%190.35M
-Dividend payable
----
----
----
----
----
----
----
----
0.00%3.75M
----
-Other payable
----
-8.80%223.61M
----
----
----
28.81%245.19M
----
2.51%201.86M
----
22.10%190.35M
Non current liabilities due within one year
168.27%2.09M
799.69%22.96M
-69.11%871.31K
-96.37%907.05K
-96.81%777.87K
-89.54%2.55M
-88.35%2.82M
1,068.08%24.99M
-57.23%24.37M
-57.30%24.39M
Other current liabilities
-24.45%922.79K
-40.20%980.59K
-44.22%992.1K
-53.90%1.08M
-67.54%1.22M
-52.33%1.64M
-51.52%1.78M
-44.51%2.35M
394.40%3.76M
310.94%3.44M
Total current liabilities
-1.38%548.57M
-18.49%508.25M
-35.65%469.71M
-35.29%456.45M
-16.44%556.27M
-7.42%623.51M
20.61%729.98M
11.79%705.34M
-20.01%665.73M
-17.53%673.45M
Current liabilities
Long term loan
----
----
--22.15M
--22.15M
--22.15M
--22.15M
----
----
----
----
Deferred tax liabilities
-16.67%4.35M
-17.11%4.42M
-17.52%4.49M
-17.91%4.56M
-6.43%5.23M
-6.41%5.34M
-6.38%5.45M
-6.36%5.56M
-12.09%5.58M
-11.90%5.7M
Long term deferred income
-17.92%20.51M
-14.02%21.51M
-13.58%22.52M
-13.17%23.52M
-11.13%24.99M
-14.17%25.02M
-13.68%26.05M
-12.57%27.09M
-6.53%28.12M
-5.84%29.15M
Lease liabilities
56.14%2.53M
-56.68%3.9M
-85.61%1.4M
-86.47%1.4M
-86.38%1.62M
-19.25%9.01M
-10.01%9.76M
-8.25%10.37M
10.51%11.88M
0.45%11.16M
Total non current liabilities
-49.25%27.39M
-51.49%29.84M
22.54%50.56M
20.03%51.63M
18.41%53.98M
33.69%61.51M
-11.93%41.26M
-38.87%43.01M
-34.25%45.58M
-34.91%46.01M
Total liabilities
-5.62%575.96M
-21.45%538.09M
-32.54%520.26M
-32.11%508.07M
-14.21%610.25M
-4.79%685.02M
18.28%771.24M
6.71%748.35M
-21.10%711.32M
-18.91%719.46M
Shareholders equity
Paid-in capital
0.00%504.25M
0.00%504.25M
0.00%504.25M
0.00%504.25M
0.00%504.25M
0.00%504.25M
-1.44%504.25M
-1.44%504.25M
16.37%504.25M
16.37%504.25M
Capital reserve funds
-0.13%4.06B
-0.06%4.06B
-0.06%4.06B
-0.06%4.06B
0.07%4.07B
0.00%4.07B
-4.52%4.07B
-4.52%4.07B
108.82%4.07B
108.82%4.07B
Surplus reserve funds
0.00%252.12M
0.00%252.12M
0.00%252.12M
0.00%252.12M
8.18%252.12M
8.18%252.12M
8.18%252.12M
8.18%252.12M
19.76%233.06M
20.68%233.06M
Retained profit
1.28%2.76B
2.95%2.67B
4.67%2.65B
5.78%2.5B
15.12%2.73B
16.12%2.59B
18.98%2.53B
16.66%2.36B
15.91%2.37B
17.05%2.23B
Shareholders equity without minority interests
0.39%7.58B
1.00%7.48B
1.57%7.47B
1.87%7.32B
5.30%7.55B
5.38%7.41B
6.11%7.36B
5.22%7.19B
61.68%7.17B
63.13%7.03B
Minority interests
-96.18%803.57K
-98.88%807.58K
-98.83%810.88K
-98.92%1.07M
-78.23%21.01M
-27.48%71.85M
-26.93%69.2M
8.52%99.19M
11.72%96.52M
18.74%99.07M
Total shareholder equity
0.12%7.58B
0.04%7.49B
0.64%7.47B
0.49%7.32B
4.19%7.57B
4.92%7.48B
5.66%7.43B
5.26%7.28B
60.73%7.27B
62.29%7.13B
Total liabilityies and equity
-0.31%8.16B
-1.77%8.02B
-2.48%7.99B
-2.54%7.83B
2.55%8.18B
4.03%8.17B
6.73%8.2B
5.40%8.03B
47.13%7.98B
48.65%7.85B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 48.09%1.99B67.53%3.25B8.73%1.86B28.07%1.96B22.16%1.34B92.75%1.94B91.83%1.71B-3.29%1.53B1.48%1.1B39.13%1.01B
Transactional financial assets -13.71%3.25B-26.44%2.24B15.00%3.71B5.28%3.36B7.89%3.77B-11.66%3.05B-5.16%3.22B18.29%3.19B271.41%3.49B263.73%3.45B
Notes receivable and accounts receivable 17.60%303.49M-29.57%322.24M-49.14%240.86M-54.56%209.84M-51.19%258.06M-20.01%457.52M-10.76%473.59M1.63%461.8M4.13%528.75M12.63%571.98M
-Notes receivable --10.38M--2.6M---------------------99.02%91.9K--------
-Accounts receivable 13.58%293.11M-30.14%319.64M-49.14%240.86M-54.55%209.84M-51.19%258.06M-20.01%457.52M-10.76%473.59M3.74%461.71M12.36%528.75M32.76%571.98M
Other receivables (including interest and dividends) -0.36%352.99M278.34%191.11M81.96%154.41M162.77%264.4M324.51%354.26M-53.13%50.51M-6.79%84.86M48.20%100.62M36.19%83.45M74.29%107.77M
-Other receivable ----278.34%191.11M-------------53.13%50.51M----48.20%100.62M----74.29%107.77M
Advance payment 256.39%12.23M-67.93%2.98M-58.98%2.62M-51.67%4.67M-36.20%3.43M130.49%9.29M-28.52%6.39M-25.75%9.66M-56.44%5.38M-63.08%4.03M
Inventories 8.26%627.58M-0.80%577.32M-8.30%566.51M-16.50%556.94M-11.76%579.7M-11.86%581.97M-7.83%617.82M-1.46%666.96M7.09%656.93M0.36%660.29M
Receivable financing -29.56%51.79M-41.02%58.46M-35.05%77.35M-37.20%66.08M-40.90%73.52M3.36%99.12M6.40%119.1M-21.28%105.22M2.56%124.41M11.30%95.91M
Other current assets 109.07%1.33M-74.24%320.58K39.18%2.61M-50.82%1.77M-67.18%638.47K348.01%1.24M-87.80%1.88M-78.09%3.59M-87.48%1.95M-98.18%277.81K
Total current assets 3.28%6.59B7.40%6.65B5.99%6.61B5.83%6.43B6.48%6.38B4.94%6.19B9.07%6.24B7.57%6.07B78.59%5.99B95.78%5.9B
Non Current assets
Other non-current financial assets -15.99%93.96M-24.85%91M-22.76%92.37M-14.26%100.39M-10.68%111.84M-8.68%121.09M-12.50%119.59M-19.23%117.09M--125.21M--132.59M
Investment real estate -7.63%611.25K-7.52%623.83K-12.73%636.42K-7.30%649.01K--661.76K--674.52K--729.27K--700.08K--------
Fixed assets -----1.66%607.7M-------------9.60%617.95M-----10.67%639.88M-----5.18%683.59M
Constru in process -----38.87%55.27M------------61.02%90.41M----69.72%69.34M-----14.17%56.15M
Intangible assets -16.13%263.14M-16.21%267.21M-13.80%265.81M-13.73%269.31M17.66%313.77M95.42%318.89M85.42%308.35M84.21%312.17M36.56%266.67M-15.15%163.19M
Development expenditure 18.85%64.77M29.91%61.19M34.50%55.93M40.49%53.22M14.25%54.49M-59.09%47.1M-61.34%41.58M-63.32%37.88M-66.24%47.7M-13.89%115.14M
Goodwill -85.41%72.61M-89.06%72.61M-89.06%72.61M-89.06%72.61M-25.02%497.77M0.00%663.84M0.00%663.84M0.00%663.84M0.00%663.84M0.00%663.84M
Long deferred expense -16.29%42.3M-23.87%31.32M-23.80%33.01M-21.95%34.93M7.47%50.53M-18.33%41.14M-20.25%43.32M-23.28%44.76M-20.53%47.02M-12.17%50.37M
Deferred tax assets 5.64%44.96M9.51%50.09M30.39%50.01M5.22%47.34M13.01%42.56M42.31%45.74M36.99%38.35M63.98%44.99M59.48%37.66M68.76%32.14M
Usufruct assets 79.96%5.17M-50.64%5.72M-83.78%2.04M-81.98%2.45M-80.45%2.87M-13.61%11.58M-5.85%12.57M-4.01%13.59M7.45%14.68M-7.20%13.41M
Other non current assets 849.18%192.26M556.96%133.81M611.19%146.95M840.58%146.18M-61.42%20.26M-52.63%20.37M-40.47%20.66M-58.22%15.54M23.38%52.5M-22.91%43M
Total non current assets -12.98%1.57B-30.44%1.38B-29.49%1.38B-28.50%1.4B-9.28%1.8B1.30%1.98B-0.09%1.96B-0.81%1.96B-3.89%1.99B-13.91%1.95B
Total assets -0.31%8.16B-1.77%8.02B-2.48%7.99B-2.54%7.83B2.55%8.18B4.03%8.17B6.73%8.2B5.40%8.03B47.13%7.98B48.65%7.85B
Liabilities
Current liabilities
Notes payable and accounts payable 56.02%219.87M-39.66%138.49M-63.22%115.83M-58.36%126.35M-52.77%140.92M-32.41%229.51M3.68%314.94M9.34%303.46M18.52%298.36M28.87%339.58M
-Notes payable 282.27%145.39M63.77%67.73M19.36%48.19M50.37%49.74M24.05%38.03M21.78%41.36M-9.92%40.38M-34.46%33.08M-61.86%30.66M-60.80%33.96M
-Accounts payable -27.62%74.47M-62.39%70.76M-75.36%67.64M-71.67%76.61M-61.57%102.89M-38.44%188.15M6.03%274.57M19.08%270.38M56.23%267.7M72.78%305.62M
Contract liabilities -31.24%4.03M-29.13%5.79M-26.91%8.15M-40.68%12.21M-67.58%5.86M-12.53%8.18M32.73%11.15M58.59%20.58M87.62%18.07M-32.37%9.35M
Advance receipts --------------110.56K------2.14K--4.29K------------
Salaries payable 0.16%89.75M-24.66%75.4M-24.96%63.67M-17.82%82.67M61.40%89.61M129.34%100.08M153.17%84.85M35.51%100.6M24.86%55.52M8.59%43.64M
Taxs payable -52.51%22.19M12.82%41.02M-23.26%41.43M-52.49%24.47M-17.65%46.73M-42.02%36.36M30.80%53.98M-18.12%51.5M-5.74%56.75M65.87%62.71M
Other payable (including interest and dividends) -22.65%209.72M-8.80%223.61M-8.33%238.76M3.36%208.65M29.80%271.15M28.81%245.19M36.81%260.45M2.51%201.86M23.94%208.9M16.49%190.35M
-Dividend payable --------------------------------0.00%3.75M----
-Other payable -----8.80%223.61M------------28.81%245.19M----2.51%201.86M----22.10%190.35M
Non current liabilities due within one year 168.27%2.09M799.69%22.96M-69.11%871.31K-96.37%907.05K-96.81%777.87K-89.54%2.55M-88.35%2.82M1,068.08%24.99M-57.23%24.37M-57.30%24.39M
Other current liabilities -24.45%922.79K-40.20%980.59K-44.22%992.1K-53.90%1.08M-67.54%1.22M-52.33%1.64M-51.52%1.78M-44.51%2.35M394.40%3.76M310.94%3.44M
Total current liabilities -1.38%548.57M-18.49%508.25M-35.65%469.71M-35.29%456.45M-16.44%556.27M-7.42%623.51M20.61%729.98M11.79%705.34M-20.01%665.73M-17.53%673.45M
Current liabilities
Long term loan ----------22.15M--22.15M--22.15M--22.15M----------------
Deferred tax liabilities -16.67%4.35M-17.11%4.42M-17.52%4.49M-17.91%4.56M-6.43%5.23M-6.41%5.34M-6.38%5.45M-6.36%5.56M-12.09%5.58M-11.90%5.7M
Long term deferred income -17.92%20.51M-14.02%21.51M-13.58%22.52M-13.17%23.52M-11.13%24.99M-14.17%25.02M-13.68%26.05M-12.57%27.09M-6.53%28.12M-5.84%29.15M
Lease liabilities 56.14%2.53M-56.68%3.9M-85.61%1.4M-86.47%1.4M-86.38%1.62M-19.25%9.01M-10.01%9.76M-8.25%10.37M10.51%11.88M0.45%11.16M
Total non current liabilities -49.25%27.39M-51.49%29.84M22.54%50.56M20.03%51.63M18.41%53.98M33.69%61.51M-11.93%41.26M-38.87%43.01M-34.25%45.58M-34.91%46.01M
Total liabilities -5.62%575.96M-21.45%538.09M-32.54%520.26M-32.11%508.07M-14.21%610.25M-4.79%685.02M18.28%771.24M6.71%748.35M-21.10%711.32M-18.91%719.46M
Shareholders equity
Paid-in capital 0.00%504.25M0.00%504.25M0.00%504.25M0.00%504.25M0.00%504.25M0.00%504.25M-1.44%504.25M-1.44%504.25M16.37%504.25M16.37%504.25M
Capital reserve funds -0.13%4.06B-0.06%4.06B-0.06%4.06B-0.06%4.06B0.07%4.07B0.00%4.07B-4.52%4.07B-4.52%4.07B108.82%4.07B108.82%4.07B
Surplus reserve funds 0.00%252.12M0.00%252.12M0.00%252.12M0.00%252.12M8.18%252.12M8.18%252.12M8.18%252.12M8.18%252.12M19.76%233.06M20.68%233.06M
Retained profit 1.28%2.76B2.95%2.67B4.67%2.65B5.78%2.5B15.12%2.73B16.12%2.59B18.98%2.53B16.66%2.36B15.91%2.37B17.05%2.23B
Shareholders equity without minority interests 0.39%7.58B1.00%7.48B1.57%7.47B1.87%7.32B5.30%7.55B5.38%7.41B6.11%7.36B5.22%7.19B61.68%7.17B63.13%7.03B
Minority interests -96.18%803.57K-98.88%807.58K-98.83%810.88K-98.92%1.07M-78.23%21.01M-27.48%71.85M-26.93%69.2M8.52%99.19M11.72%96.52M18.74%99.07M
Total shareholder equity 0.12%7.58B0.04%7.49B0.64%7.47B0.49%7.32B4.19%7.57B4.92%7.48B5.66%7.43B5.26%7.28B60.73%7.27B62.29%7.13B
Total liabilityies and equity -0.31%8.16B-1.77%8.02B-2.48%7.99B-2.54%7.83B2.55%8.18B4.03%8.17B6.73%8.2B5.40%8.03B47.13%7.98B48.65%7.85B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data